BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 17616711)

  • 21. Epigallocatechin gallate inhibits human tongue carcinoma cells via HK2‑mediated glycolysis.
    Gao F; Li M; Liu WB; Zhou ZS; Zhang R; Li JL; Zhou KC
    Oncol Rep; 2015 Mar; 33(3):1533-9. PubMed ID: 25591943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigallocatechin-3-gallate induces growth inhibition and apoptosis of human anaplastic thyroid carcinoma cells through suppression of EGFR/ERK pathway and cyclin B1/CDK1 complex.
    Lim YC; Cha YY
    J Surg Oncol; 2011 Dec; 104(7):776-80. PubMed ID: 21725973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells.
    Masuda M; Suzui M; Lim JT; Weinstein IB
    Clin Cancer Res; 2003 Aug; 9(9):3486-91. PubMed ID: 12960141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.
    Chow HH; Cai Y; Alberts DS; Hakim I; Dorr R; Shahi F; Crowell JA; Yang CS; Hara Y
    Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):53-8. PubMed ID: 11205489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
    Farabegoli F; Papi A; Orlandi M
    Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells.
    Chen C; Shen G; Hebbar V; Hu R; Owuor ED; Kong AN
    Carcinogenesis; 2003 Aug; 24(8):1369-78. PubMed ID: 12819184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells.
    Jung YD; Kim MS; Shin BA; Chay KO; Ahn BW; Liu W; Bucana CD; Gallick GE; Ellis LM
    Br J Cancer; 2001 Mar; 84(6):844-50. PubMed ID: 11259102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells.
    Shimizu M; Deguchi A; Hara Y; Moriwaki H; Weinstein IB
    Biochem Biophys Res Commun; 2005 Sep; 334(3):947-53. PubMed ID: 16053920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Green tea phenolics inhibit butyrate-induced differentiation of colon cancer cells by interacting with monocarboxylate transporter 1.
    Sánchez-Tena S; Vizán P; Dudeja PK; Centelles JJ; Cascante M
    Biochim Biophys Acta; 2013 Dec; 1832(12):2264-70. PubMed ID: 23994611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The specific anti-cancer activity of green tea (-)-epigallocatechin-3-gallate (EGCG).
    Wang YC; Bachrach U
    Amino Acids; 2002; 22(2):131-43. PubMed ID: 12395181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea.
    Ju J; Hong J; Zhou JN; Pan Z; Bose M; Liao J; Yang GY; Liu YY; Hou Z; Lin Y; Ma J; Shih WJ; Carothers AM; Yang CS
    Cancer Res; 2005 Nov; 65(22):10623-31. PubMed ID: 16288056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigallocatechin-3-gallate, a green-tea polyphenol, suppresses Rho signaling in TWNT-4 human hepatic stellate cells.
    Higashi N; Kohjima M; Fukushima M; Ohta S; Kotoh K; Enjoji M; Kobayashi N; Nakamuta M
    J Lab Clin Med; 2005 Jun; 145(6):316-22. PubMed ID: 15976760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.
    Shirakami Y; Shimizu M; Adachi S; Sakai H; Nakagawa T; Yasuda Y; Tsurumi H; Hara Y; Moriwaki H
    Cancer Sci; 2009 Oct; 100(10):1957-62. PubMed ID: 19558547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of tea catechin (-)-epigallocatechin gallate with lipid bilayers.
    Sun Y; Hung WC; Chen FY; Lee CC; Huang HW
    Biophys J; 2009 Feb; 96(3):1026-35. PubMed ID: 19186140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: structure-activity relationship and mechanisms involved.
    Chung JY; Huang C; Meng X; Dong Z; Yang CS
    Cancer Res; 1999 Sep; 59(18):4610-7. PubMed ID: 10493515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compartmentalization of epidermal growth factor receptor in liver plasma membrane.
    Wang Y; Posner BI; Balbis A
    J Cell Biochem; 2009 May; 107(1):96-103. PubMed ID: 19288512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sigma-1 receptors potentiate epidermal growth factor signaling towards neuritogenesis in PC12 cells: potential relation to lipid raft reconstitution.
    Takebayashi M; Hayashi T; Su TP
    Synapse; 2004 Aug; 53(2):90-103. PubMed ID: 15170821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells.
    Rieger-Christ KM; Hanley R; Lodowsky C; Bernier T; Vemulapalli P; Roth M; Kim J; Yee AS; Le SM; Marie PJ; Libertino JA; Summerhayes IC
    J Cell Biochem; 2007 Oct; 102(2):377-88. PubMed ID: 17348027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-kappaB activation in normal human bronchial epithelial cells.
    Syed DN; Afaq F; Kweon MH; Hadi N; Bhatia N; Spiegelman VS; Mukhtar H
    Oncogene; 2007 Feb; 26(5):673-82. PubMed ID: 16862172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of green tea extract and EGCG on the signaling network in squamous cell carcinoma.
    Liu X; Zhang DY; Zhang W; Zhao X; Yuan C; Ye F
    Nutr Cancer; 2011; 63(3):466-75. PubMed ID: 21391127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.